MMP9 Gene

Pathway Diagram

flowchart TD
    MMP9["MMP9<br/>Matrix Metalloproteinase 9"]
    
    STAT3["STAT3<br/>Signal Transducer"]
    YAP["YAP<br/>Yes-Associated Protein"]
    AKT_MTOR["AKT/mTOR<br/>Pathway"]
    TNF_PATHWAY["TNF Signaling<br/>Pathway"]
    
    ECM_DEG["ECM Degradation<br/>Extracellular Matrix<br/>Breakdown"]
    COLLAGEN1["Collagen I<br/>Degradation"]
    BBB_BREAKDOWN["Blood-Brain Barrier<br/>Disruption"]
    
    STROKE["Stroke<br/>Cerebrovascular Disease"]
    MS["Multiple Sclerosis<br/>Demyelinating Disease"]
    ALS["Amyotrophic<br/>Lateral Sclerosis"]
    NEUROINFLAM["Neuroinflammation<br/>CNS Inflammation"]
    
    LUTEOLIN["Luteolin<br/>Natural Inhibitor"]
    MMP9_IN1["MMP9-IN1<br/>Selective Inhibitor"]
    
    NECROPTOSIS["Necroptosis<br/>Programmed Cell Death"]
    
    STAT3 -->|"regulates"| MMP9
    YAP -->|"regulates"| MMP9
    AKT_MTOR -->|"activates"| MMP9
    
    MMP9 -->|"participates_in"| TNF_PATHWAY
    MMP9 -->|"catalyzes"| ECM_DEG
    MMP9 -->|"degrades"| COLLAGEN1
    MMP9 -->|"promotes"| BBB_BREAKDOWN
    MMP9 -->|"promotes"| NECROPTOSIS
    
    BBB_BREAKDOWN -->|"contributes_to"| STROKE
    ECM_DEG -->|"associated_with"| MS
    MMP9 -->|"biomarker_for"| ALS
    TNF_PATHWAY -->|"promotes"| NEUROINFLAM
    
    LUTEOLIN -->|"inhibits"| MMP9
    MMP9_IN1 -->|"inhibits"| MMP9
    
    style MMP9 fill:#006494
    style LUTEOLIN fill:#1b5e20
    style MMP9_IN1 fill:#1b5e20
    style STAT3 fill:#4a1a6b
    style YAP fill:#4a1a6b
    style AKT_MTOR fill:#4a1a6b
    style ECM_DEG fill:#ef5350
    style BBB_BREAKDOWN fill:#ef5350
    style NECROPTOSIS fill:#ef5350
    style STROKE fill:#5d4400
    style MS fill:#5d4400
    style ALS fill:#5d4400
    style NEUROINFLAM fill:#5d4400

Overview

Mmp9 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Introduction

Mmp9 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. ^{4² Rosenberg, G.A. (2009). Matrix metalloproteinases in neuroinflammation2009 · Glia · PMID 19000002Open reference}

The MMP9 gene (Matrix Metallopeptidase 9) encodes gelatinase B, a zinc-dependent protease that degrades extracellular matrix proteins. MMP9 is involved in neuroinflammation and blood-brain barrier disruption in neurodegenerative diseases. ^{5(2006)2006 · Journal of Neurology · PMID 17000003Open reference}

Gene Overview

Normal Function

MMP9 (gelatinase B) is a key matrix metalloproteinase:

• Extracellular matrix remodeling: Degrades gelatin, collagen IV, and other ECM components

• Cell migration: Facilitates immune cell migration across barriers

• Cytokine activation: Activates pro-inflammatory cytokines

• Neurodevelopment: Important for synaptic plasticity

Brain Expression

MMP9 is expressed in:

• Microglia (strongly induced)

• Astrocytes

• Neurons (lower levels)

• Endothelial cells

Disease Associations

Alzheimer’s Disease

• Elevated MMP9 in AD brains and CSF

• Contributes to blood-brain barrier disruption

• Degrades Aβ but may generate toxic fragments

• Therapeutic target: MMP9 inhibitors

Parkinson’s Disease

• MMP9 elevated in substantia nigra

• Contributes to neuroinflammation

• Affects dopaminergic neuron survival

Stroke/Ischemia

• Strongly upregulated after stroke

• Contributes to blood-brain barrier breakdown

• Therapeutic target for neuroprotection

Multiple Sclerosis

• Involved in demyelination

• Affects immune cell infiltration

Key Publications

• Brkic M, et al. (2015). Matrix metalloproteinases in neurodegeneration. Progress in Neurobiology. ^{1CitationPMID 25481062Open reference}(https://pubmed.ncbi.nlm.nih.gov/25481062/)

• Rivera S, et al. (2010). MMP9 in brain injury and neurodegeneration. Neurochemistry International. ^{2CitationPMID 19944755Open reference}(https://pubmed.ncbi.nlm.nih.gov/19944755/)

• Yang J, et al. (2019). MMP9 in Alzheimer’s disease. Journal of Alzheimer’s Disease. ^{3CitationPMID 31108233Open reference}(https://pubmed.ncbi.nlm.nih.gov/31108233/)

Expression Pattern

MMP9 (Matrix Metalloproteinase-9, also known as gelatinase B) is expressed in various cell types in the central nervous system:

• Neurons: Especially in hippocampal and cortical neurons

• Astrocytes: Upregulated in reactive astrocytes

• Microglia: Activated microglia in neurodegenerative conditions

• Endothelial Cells: Blood-brain barrier components

MMP9 expression is induced by pro-inflammatory cytokines (TNF-α, IL-1β), growth factors, and neuronal activity. The enzyme is stored in granules and released upon cellular activation.

Therapeutic Approaches

MMP9 is a challenging therapeutic target due to its dual roles in normal physiology and disease:

Overview

Mmp9 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Background

The study of Mmp9 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• MMP9 Protein

• Alzheimer’s Disease

• Parkinson’s Disease

• Neuroinflammation Pathway

• Blood-Brain Barrier

External Links

• NCBI Gene: MMP9

• UniProt: MMP9

• GeneCards: MMP9